Literature DB >> 7490470

Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa.

M J Gijbels1, H HogenEsch, P L Bruijnzeel, G R Elliott, C Zurcher.   

Abstract

Chronic proliferative dermatitis is a spontaneous mutation in C57BL/Ka mice (cpdm/cpdm) and is characterized by epithelial hyperproliferation, infiltration by eosinophils and macrophages, and vascular dilatation. To elucidate whether these pathologic features are the result of a local (skin) process or a consequence of a systemic disorder, transplantations were performed of full-thickness grafts of affected skin from cpdm/cpdm mice and normal skin from control (C57BL/Ka) mice on the back of cpdm/cpdm, C57BL/Ka and athymic nude mice. After 3 months, the grafts maintained the histologic phenotype of the donor animal. Intercellular adhesion molecule-1 continued to be expressed by basal keratinocytes of the cpdm/cpdm grafts after transplantation. In contrast, the basal keratinocytes of the C57BL/Ka grafts onto cpdm/cpdm mice remained negative for intercellular adhesion molecule-1 3 months after transplantation. An increased number of proliferating keratinocytes was present in the cpdm/cpdm skin-graft transplanted to nudes or to C57BL/Ka mice based on short-term bromodeoxyuridine labeling. The bromodeoxyuridine incorporation in the keratinocytes of the control C57BL/Ka skin grafts transplanted to cpdm/cpdm, nude, or C57BL/Ka mice was the same as in the keratinocytes of normal C57BL/Ka mice. This study demonstrates that the pathologic features found in the cpdm/cpdm mice are the result of a disorder in the epidermis or dermis and not due to a systemic defect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490470     DOI: 10.1111/1523-1747.ep12325599

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm).

Authors:  M J Gijbels; C Zurcher; G Kraal; G R Elliott; H HogenEsch; G Schijff; H F Savelkoul; P L Bruijnzeel
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

2.  Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses.

Authors:  Daniel E Zak; Frank Schmitz; Elizabeth S Gold; Alan H Diercks; Jacques J Peschon; Joe S Valvo; Antti Niemistö; Irina Podolsky; Shannon G Fallen; Rosa Suen; Tetyana Stolyar; Carrie D Johnson; Kathleen A Kennedy; M Kristina Hamilton; Owen M Siggs; Bruce Beutler; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

3.  Linear ubiquitination prevents inflammation and regulates immune signalling.

Authors:  Björn Gerlach; Stefanie M Cordier; Anna C Schmukle; Christoph H Emmerich; Eva Rieser; Tobias L Haas; Andrew I Webb; James A Rickard; Holly Anderton; Wendy W-L Wong; Ueli Nachbur; Lahiru Gangoda; Uwe Warnken; Anthony W Purcell; John Silke; Henning Walczak
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

Review 4.  Autoinflammatory Skin Disorders: The Inflammasomme in Focus.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2016-06-03       Impact factor: 11.951

5.  TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice.

Authors:  James A Rickard; Holly Anderton; Nima Etemadi; Ueli Nachbur; Maurice Darding; Nieves Peltzer; Najoua Lalaoui; Kate E Lawlor; Hannah Vanyai; Cathrine Hall; Aleks Bankovacki; Lahiru Gangoda; Wendy Wei-Lynn Wong; Jason Corbin; Chunzi Huang; Edward S Mocarski; James M Murphy; Warren S Alexander; Anne K Voss; David L Vaux; William J Kaiser; Henning Walczak; John Silke
Journal:  Elife       Date:  2014-12-02       Impact factor: 8.140

Review 6.  Linear ubiquitination in immunity.

Authors:  Yutaka Shimizu; Lucia Taraborrelli; Henning Walczak
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

7.  Distinct role of IL-1β in instigating disease in Sharpincpdm mice.

Authors:  Prajwal Gurung; Bhesh Raj Sharma; Thirumala-Devi Kanneganti
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

8.  Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice.

Authors:  Emilia Peuhu; Siiri I Salomaa; Nicola De Franceschi; Christopher S Potter; John P Sundberg; Jeroen Pouwels
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

9.  Modulation of autoimmune pathogenesis by T cell-triggered inflammatory cell death.

Authors:  Katsuhiro Sasaki; Ai Himeno; Tomoko Nakagawa; Yoshiteru Sasaki; Hiroshi Kiyonari; Kazuhiro Iwai
Journal:  Nat Commun       Date:  2019-08-28       Impact factor: 14.919

10.  Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling.

Authors:  Christopher S Potter; Zhe Wang; Kathleen A Silva; Victoria E Kennedy; Timothy M Stearns; Lisa Burzenski; Leonard D Shultz; Harm Hogenesch; John P Sundberg
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.